• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的去泛素化酶:机制及治疗意义

DUBs in Alzheimer's disease: mechanisms and therapeutic implications.

作者信息

Qin Biying, Chen Xiaodong, Wang Feng, Wang Yanfeng

机构信息

Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China.

Tangshan Research Institute, Beijing Institute of Technology, Tangshan, Hebei, China.

出版信息

Cell Death Discov. 2024 Nov 20;10(1):475. doi: 10.1038/s41420-024-02237-3.

DOI:10.1038/s41420-024-02237-3
PMID:39562545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11576995/
Abstract

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by the accumulation of amyloid β protein (Aβ) and the hyper-phosphorylation of the microtubule-associated protein Tau. The ubiquitin-proteasome system (UPS) plays a pivotal role in determining the fate of proteins, and its dysregulation can contribute to the buildup of Aβ and Tau. Deubiquitinating enzymes (DUBs), working in conjunction with activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3), actively maintain the delicate balance of protein homeostasis. DUBs specifically remove ubiquitin tags from proteins marked for degradation, thereby averting their proteasomal breakdown. Several DUBs have demonstrated their capacity to regulate the levels of Aβ and Tau by modulating their degree of ubiquitination, underscoring their potential as therapeutic targets for AD. In this context, we present a comprehensive review of AD-associated DUBs and elucidate their physiological roles. Moreover, we delve into the current advancements in developing inhibitors targeting these DUBs, including the determination of cocrystal structures with their respective targets. Additionally, we assess the therapeutic efficacy of these inhibitors in AD, aiming to establish a theoretical foundation for future AD treatments.

摘要

阿尔茨海默病(AD)是一种常见的神经退行性疾病,其特征在于淀粉样β蛋白(Aβ)的积累以及微管相关蛋白Tau的过度磷酸化。泛素 - 蛋白酶体系统(UPS)在决定蛋白质的命运中起关键作用,其失调可导致Aβ和Tau的积累。去泛素化酶(DUBs)与激活酶(E1)、泛素结合酶(E2)和泛素连接酶(E3)协同作用,积极维持蛋白质稳态的微妙平衡。DUBs特异性地从标记为降解的蛋白质上移除泛素标签,从而避免其被蛋白酶体分解。几种DUBs已证明能够通过调节Aβ和Tau的泛素化程度来调节它们的水平,凸显了它们作为AD治疗靶点的潜力。在此背景下,我们对与AD相关的DUBs进行了全面综述,并阐明了它们的生理作用。此外,我们深入探讨了开发针对这些DUBs的抑制剂的当前进展,包括与各自靶点的共晶体结构的确定。此外,我们评估了这些抑制剂在AD中的治疗效果,旨在为未来的AD治疗建立理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/7cf264296947/41420_2024_2237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/a86f126a4e28/41420_2024_2237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/e5bb7b3f1c9f/41420_2024_2237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/0f1b4248eb73/41420_2024_2237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/7cf264296947/41420_2024_2237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/a86f126a4e28/41420_2024_2237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/e5bb7b3f1c9f/41420_2024_2237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/0f1b4248eb73/41420_2024_2237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac5/11576995/7cf264296947/41420_2024_2237_Fig4_HTML.jpg

相似文献

1
DUBs in Alzheimer's disease: mechanisms and therapeutic implications.阿尔茨海默病中的去泛素化酶:机制及治疗意义
Cell Death Discov. 2024 Nov 20;10(1):475. doi: 10.1038/s41420-024-02237-3.
2
Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.阿尔茨海默病中β-淀粉样蛋白与泛素-蛋白酶体系统的关系。
Neurol Res. 2014 Mar;36(3):276-82. doi: 10.1179/1743132813Y.0000000288.
3
Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.去泛素化酶调控神经退行性疾病中的细胞功能。
Ageing Res Rev. 2021 Aug;69:101367. doi: 10.1016/j.arr.2021.101367. Epub 2021 May 21.
4
The potential roles of deubiquitinating enzymes in brain diseases.去泛素化酶在脑部疾病中的潜在作用。
Ageing Res Rev. 2020 Aug;61:101088. doi: 10.1016/j.arr.2020.101088. Epub 2020 May 26.
5
E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.E3 连接酶和去泛素化酶靶向铁死亡:神经退行性疾病的潜在治疗策略。
Biomed Pharmacother. 2024 Jun;175:116753. doi: 10.1016/j.biopha.2024.116753. Epub 2024 May 17.
6
Deubiquitinases in skeletal muscle-the underappreciated side of the ubiquitination coin.骨骼肌中的去泛素化酶——泛素化这枚硬币被忽视的一面。
Am J Physiol Cell Physiol. 2024 Dec 1;327(6):C1651-C1665. doi: 10.1152/ajpcell.00553.2024. Epub 2024 Sep 30.
7
The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases.功能失调的泛素酶在大多数常见疾病发病机制中的作用。
Int J Mol Sci. 2020 Sep 1;21(17):6335. doi: 10.3390/ijms21176335.
8
Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.与阿尔茨海默病相关的异常E3连接酶的探索及调节其功能的化学工具的开发。
Front Cell Neurosci. 2021 Nov 18;15:768655. doi: 10.3389/fncel.2021.768655. eCollection 2021.
9
The Ubiquitin System in Alzheimer's Disease.阿尔茨海默病中的泛素系统。
Adv Exp Med Biol. 2020;1233:195-221. doi: 10.1007/978-3-030-38266-7_8.
10
Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases.去泛素化酶(DUBs):揭示神经退行性疾病的潜在基础。
Mol Psychiatry. 2022 Jan;27(1):259-268. doi: 10.1038/s41380-021-01233-8. Epub 2021 Jul 20.

引用本文的文献

1
Advancement in modeling of Alzheimer's disease: a comprehensive review of preclinical screening platforms.阿尔茨海默病建模的进展:临床前筛查平台的全面综述
Front Aging Neurosci. 2025 Aug 6;17:1646551. doi: 10.3389/fnagi.2025.1646551. eCollection 2025.
2
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
3
Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.

本文引用的文献

1
The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.USP10/13 抑制剂 spautin-1 通过独立调控 RAF-ERK 介导的糖酵解和 SKP2 来抑制神经胶质瘤的进展。
Biochim Biophys Acta Mol Basis Dis. 2024 Oct;1870(7):167291. doi: 10.1016/j.bbadis.2024.167291. Epub 2024 Jun 8.
2
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.UCHL1 是神经内分泌癌的一个有潜力的分子标志物和治疗靶点。
Cell Rep Med. 2024 Feb 20;5(2):101381. doi: 10.1016/j.xcrm.2023.101381. Epub 2024 Jan 19.
3
Altered gene expression in excitatory neurons is associated with Alzheimer's disease and its higher incidence in women.
神经系统中的泛素化:从分子机制到疾病影响
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05220-w.
4
Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance.抗击疟疾:靶向泛素-蛋白酶体系统以克服耐药性
Trop Med Infect Dis. 2025 Apr 3;10(4):94. doi: 10.3390/tropicalmed10040094.
兴奋性神经元中基因表达的改变与阿尔茨海默病及其在女性中较高的发病率有关。
Alzheimers Dement (N Y). 2023 Feb 8;9(1):e12373. doi: 10.1002/trc2.12373. eCollection 2023 Jan-Mar.
4
Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review).泛素羧基末端水解酶L1:一种具有双重作用的新型癌症标志物和治疗靶点(综述)
Oncol Lett. 2023 Feb 8;25(3):123. doi: 10.3892/ol.2023.13709. eCollection 2023 Mar.
5
USP11 plays a critical role in the onset and progression of acute graft-versus-host disease:Novel target for precision therapeutics.USP11在急性移植物抗宿主病的发生和发展中起关键作用:精准治疗的新靶点。
Pharmacol Res. 2023 Mar;189:106707. doi: 10.1016/j.phrs.2023.106707. Epub 2023 Feb 21.
6
Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity.一类具有广谱抗癌活性的高效USP25/28抑制剂的鉴定。
Signal Transduct Target Ther. 2022 Dec 8;7(1):393. doi: 10.1038/s41392-022-01209-2.
7
Ubiquitin-specific protease 20 in human disease: Emerging role and therapeutic implications.泛素特异性蛋白酶 20 在人类疾病中的作用:新兴作用和治疗意义。
Biochem Pharmacol. 2022 Dec;206:115352. doi: 10.1016/j.bcp.2022.115352. Epub 2022 Nov 21.
8
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer.发现强效 OTUB1/USP8 双重抑制剂,靶向非小细胞肺癌的蛋白质平衡。
J Med Chem. 2022 Oct 27;65(20):13645-13659. doi: 10.1021/acs.jmedchem.2c00408. Epub 2022 Oct 11.
9
Structural basis for specific inhibition of the deubiquitinase UCHL1.UCHL1 去泛素化酶特异性抑制的结构基础。
Nat Commun. 2022 Oct 10;13(1):5950. doi: 10.1038/s41467-022-33559-4.
10
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women.X 连锁泛素特异性肽酶 11 增加女性 tau 病易感性。
Cell. 2022 Oct 13;185(21):3913-3930.e19. doi: 10.1016/j.cell.2022.09.002. Epub 2022 Oct 4.